Continuation of methotrexate resulted in better clinical and radiographic outcomes than discontinuation upon starting etanercept in patients with rheumatoid arthritis: 52-week results from the JESMR study.

Abstract

MTX should be continued when starting ETN in patients with active RA. (ClinicalTrials.gov: NCT00688103).

Full Text

• DOI - The Journal of rheumatology (DOI)
• Swets Information Services - full-text online
• HighWire Press - full-text online
• EBSCO - full-text online

Subjects

• Aged
• Antirheumatic Agents
• Arthritis, Rheumatoid
• Disease Progression
• Drug Therapy, Combination
• Female
• Humans
• Immunoglobulin G
• Methotrexate
• Middle Aged
• Prospective Studies
• Receptors, Tumor Necrosis Factor
• Treatment Outcome

Similar articles

• High incidence of intermittent care in HIV-1-infected patients in Curaçao before and after starting cART. (2013-02-21)
• Choice of starting dose for molecularly targeted agents evaluated in first-in-human phase I cancer clinical trials. (2010-03-09)
• Starting dose of levothyroxine for the treatment of congenital hypothyroidism: a systematic review. (2002-04-30)
• Potential formula for the calculation of starting and incremental insulin glargine doses: ALOHA subanalysis. (2012-08-01)
• Factors associated with timely initiation of antiretroviral therapy in two HIV clinics in Lilongwe, Malawi. (2013-03-06)
• A Review of Study Designs and Outcomes of Phase I Clinical Studies of Nanoparticle Agents Compared with Small Molecule Anticancer Agents. (2013-04-25)
• Excellent long time survival for Swedish patients starting home-hemodialysis with and without subsequent renal transplantations. (2013-04-11)
• Optimal starting gantry angles using equiangular-spaced beams with intensity modulated radiation therapy for prostate cancer on RTOG 0126: a clinical study of 5 and 7 fields. (2007-12-06)
• Methadone toxicity causing death in ten subjects starting on a methadone maintenance program. (1993-03-18)
• Weight change associated with antiepileptic drugs. (2012-12-12)

Authors

• Hideto Kameda
• Katsuaki Kanbe
• Eri Sato
• Yukitaka Ueki
• Kazuyoshi Saito
• Shouhei Nagaoka
• Toshihiko Hidaka
• Tatsuya Atsumi
• Michishi Tsukano
• Tsuyoshi Kasama
• Shunichi Shiozawa
• Yoshiya Tanaka
• Hisashi Yamanaka
• Tsutomu Takeuchi

Publication date

2011-08-02

Journal

Journal topics

• Arthritis
• Rheumatic Diseases

Language

Eng.

Copyright

The Journal of rheumatology

Japan Biological Agent Integrated Consortium (JBASIC), Keio University, Tokyo, Japan. kamehide [at] z6.keio.jp

Release reference

J Rheumatol. 2011 Aug;38(8):1585-92

Related books

• Books of Antirheumatic Agents
• Books of Arthritis
• Books of Arthritis, Rheumatoid
• Books of Disease Progression
• Books of Drug Therapy, Combination
• Books of Immunoglobulin G
• Books of Methotrexate
• Books of Prospective Studies
• Books of Receptors, Tumor Necrosis Factor
• Books of Rheumatic Diseases
• Books of Treatment Outcome